Cargando…

Directly Measured vs. Calculated Low-Density Lipoprotein Cholesterol Does Not Identify Additional Individuals With Coronary Artery Disease and Diabetes at Higher Risk of Adverse Events: Insight From a Large Percutaneous Coronary Intervention Cohort in Asia

BACKGROUND: The objective of our study was to assess whether calculated low-density lipoprotein cholesterol (LDL-C) is inferior to direct LDL-C (dLDL-C) in identifying patients at higher risk of all-cause mortality, recurrent acute myocardial infarction (AMI), and major adverse cardiovascular event...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Boqun, Wang, Hao-Yu, Liu, Jinpeng, Cai, Zhongxing, Song, Chenxi, Jia, Lei, Yin, Dong, Wang, Hongjian, Dou, Ke-Fei, Song, Weihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301080/ https://www.ncbi.nlm.nih.gov/pubmed/35872896 http://dx.doi.org/10.3389/fcvm.2022.932878

Ejemplares similares

Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Shi, Boqun, et al.
Publicado: (2023)

How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?
por: Cui, Kongyong, et al.
Publicado: (2022)

Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease
por: Shi, Boqun, et al.
Publicado: (2022)

Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations
por: Cui, Kongyong, et al.
Publicado: (2021)

The Effect of a WeChat-Based Tertiary A-Level Hospital Intervention on Medication Adherence and Risk Factor Control in Patients With Stable Coronary Artery Disease: Multicenter Prospective Study
por: Shi, Boqun, et al.
Publicado: (2021)

Development and Validation of a Nomogram for Predicting the Risk of Adverse Cardiovascular Events in Patients with Coronary Artery Ectasia
por: Cai, Zhongxing, et al.
Publicado: (2021)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Sleep quality and risk of coronary heart disease - a prospective cohort study from the English longitudinal study of ageing
por: Song, Chenxi, et al.
Publicado: (2020)

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention
por: Seo, Suk Min, et al.
Publicado: (2011)

Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Wu, Ting-Ting, et al.
Publicado: (2019)

Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
por: You, Jiayin, et al.
Publicado: (2020)

Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia
por: Cai, Zhongxing, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Independent Prognostic Value of High-sensitivity C-reactive Protein in Patients with Coronary Artery Ectasia
por: Wang, Yintang, et al.
Publicado: (2016)

Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease
por: Hannan, Edward L., et al.
Publicado: (2021)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention)
por: Chen, Lijuan, et al.
Publicado: (2023)

Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia
por: Jafari, Jamal, et al.
Publicado: (2019)

High‐Intensity Versus Non‐High‐Intensity Statins in Patients Achieving Low‐Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention
por: Kim, Juwon, et al.
Publicado: (2018)

Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study
por: Dai, Xin-Ya, et al.
Publicado: (2019)

Effect of type 2 diabetes on coronary artery ectasia: smaller lesion diameter and shorter lesion length but similar adverse cardiovascular events
por: Cai, Zhongxing, et al.
Publicado: (2022)

The value of the MIND diet in the primary and secondary prevention of hypertension: A cross-sectional and longitudinal cohort study from NHANES analysis
por: Song, Yanjun, et al.
Publicado: (2023)

Time Trends of Ventricular Reconstruction and Outcomes among Patients with Left Ventricular Thrombus and Aneurysms
por: Shi, Boqun, et al.
Publicado: (2022)

Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery disease
por: Hsu, Po-Chao, et al.
Publicado: (2013)

High-Intensity Statin vs. Low-Density Lipoprotein Cholesterol Target for Patients Undergoing Percutaneous Coronary Intervention: Insights From a Territory-Wide Cohort Study in Hong Kong
por: Ng, Andrew Kei-Yan, et al.
Publicado: (2021)

Serum concentrations of small dense low‐density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis
por: Chen, Si, et al.
Publicado: (2021)

High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients
por: Hu, Ziyang, et al.
Publicado: (2021)

Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention
por: Harada, Kazuhiro, et al.
Publicado: (2018)

Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention
por: Fukase, Tatsuya, et al.
Publicado: (2023)

Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
por: Sun, Cathy J, et al.
Publicado: (2019)

The Effect of Total Cholesterol Variability on Clinical Outcomes After Percutaneous Coronary Intervention
por: Liang, Yanting, et al.
Publicado: (2022)

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

The Use of Thromboelastography in Percutaneous Coronary Intervention and Acute Coronary Syndrome in East Asia: A Systematic Literature Review
por: Xu, Ou, et al.
Publicado: (2022)

Dyslipidemia and Rate of Under-Target Low-Density Lipoprotein-Cholesterol in Patients with Coronary Artery Disease in Korea
por: Lee, Sang-Hak, et al.
Publicado: (2019)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Fractional esterification rate of cholesterol in high-density lipoprotein associates with risk of coronary heart disease
por: Liu, Junmeng, et al.
Publicado: (2017)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease
por: Gao, Jie, et al.
Publicado: (2022)

Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization
por: Barry, Arden R., et al.
Publicado: (2019)

HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study
por: Song, Chenxi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ucdc5j4pfunctrdtl34591qrr